Manzo Pharmaceuticals, Inc.
MNZO
$0.0001
$0.000.00%
OTC PK
| 09/30/2005 | 06/30/2005 | 03/31/2005 | 12/31/2004 | 09/30/2004 | |
|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 3.07M | 3.07M | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 0.00 | 0.00 | 3.07M | 3.07M | -- |
| Cost of Revenue | 517.10K | 390.10K | 3.31M | 3.05M | -- |
| Gross Profit | -517.10K | -390.10K | -243.00K | 21.00K | -- |
| SG&A Expenses | 3.72M | 3.77M | 3.38M | 2.87M | -- |
| Depreciation & Amortization | 84.70K | 86.60K | 344.00K | 344.00K | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 4.33M | 4.25M | 7.04M | 6.27M | -- |
| Operating Income | -4.33M | -4.25M | -3.97M | -3.20M | -- |
| Income Before Tax | 7.75M | 7.96M | 8.09M | -4.15M | -- |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 7.75 | 7.96 | 8.09 | -4.15 | -- |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 7.75M | 7.96M | 8.09M | -4.15M | -- |
| EBIT | -4.33M | -4.25M | -3.97M | -3.20M | -- |
| EBITDA | -4.24M | -4.16M | -3.80M | -2.85M | -- |
| EPS Basic | 2.35 | 2.29 | 2.32 | -1.20 | -- |
| Normalized Basic EPS | -0.26 | -0.30 | -0.27 | -0.75 | -- |
| EPS Diluted | 2.09 | 2.03 | 2.07 | -1.23 | -- |
| Normalized Diluted EPS | -0.28 | -0.33 | -0.29 | -0.75 | -- |
| Average Basic Shares Outstanding | 15.85M | 14.10M | 13.97M | 13.86M | -- |
| Average Diluted Shares Outstanding | 16.13M | 14.38M | 14.25M | 13.86M | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |